We are live on ! Find out more
Winslow Capital Management

Winslow Capital Management Portfolio holdings

AUM $25.6B
1-Year Est. Return 33.75%
This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+33.75%
3 Year Est. Return
+154.66%
5 Year Est. Return
+213.06%
10 Year Est. Return
+1,176.99%
AUM
$18.2B
AUM Growth
-$389M
Cap. Flow
-$1.52B
Cap. Flow %
-8.38%
Top 10 Hldgs %
35.41%
Holding
106
New
10
Increased
18
Reduced
55
Closed
7

Top Buys

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$224M
2
CI icon
Cigna
CI
+$178M
3
BAX icon
Baxter International
BAX
+$177M
4
BA icon
Boeing
BA
+$171M
5
MSFT icon
Microsoft
MSFT
+$159M

Sector Composition

Rank Sector Weight
1 Technology 27.26%
2 Consumer Discretionary 16.43%
3 Healthcare 14.28%
4 Communication Services 13.49%
5 Financials 12.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
51
Netflix
NFLX
$299B
$183M 1.01%
9,518,640
-841,530
-8% -$16.2M
CI icon
52
Cigna
CI
$73.8B
$181M 1%
+892,584
New +$178M
LLY icon
53
Eli Lilly
LLY
$1.02T
$180M 0.99%
2,136,089
-1,674,453
-44% -$142M
BAX icon
54
Baxter International
BAX
$13.5B
$179M 0.98%
+2,763,772
New +$177M
BDX icon
55
Becton Dickinson
BDX
$45.6B
$174M 0.96%
834,837
-471,438
-36% -$98.7M
RACE icon
56
Ferrari
RACE
$69.3B
$162M 0.89%
1,547,162
-136,373
-8% -$15.2M
CMCSA icon
57
Comcast
CMCSA
$85B
$95.7M 0.53%
2,390,391
+2,390,254
+1,744,711% +$89.9M
CARG icon
58
CarGurus
CARG
$3.27B
$83M 0.46%
+2,768,004
New +$82.7M
IWF icon
59
iShares Russell 1000 Growth ETF
IWF
$121B
$15M 0.08%
444,064
+295,636
+199% +$9.69M
A icon
60
Agilent Technologies
A
$39.1B
$1.45M 0.01%
+21,580
New +$1.46M
LBRDA icon
61
Liberty Broadband Class A
LBRDA
$4.89B
$1.39M 0.01%
+16,380
New +$1.44M
CME icon
62
CME Group
CME
$96.3B
$1.24M 0.01%
+8,460
New +$1.2M
ABT icon
63
Abbott
ABT
$183B
$768K ﹤0.01%
+13,460
New +$746K
BSX icon
64
Boston Scientific
BSX
$69.5B
$154K ﹤0.01%
6,197
-11,855,199
-100% -$327M
SWKS icon
65
Skyworks Solutions
SWKS
$9.37B
$47K ﹤0.01%
496
-1,641,499
-100% -$171M
CELG
66
DELISTED
Celgene Corp
CELG
$46K ﹤0.01%
436
-3,327,956
-100% -$376M
VUG icon
67
Vanguard Morningstar Growth ETF
VUG
$220B
$34K ﹤0.01%
1,470
+1,410
+2,350% +$32.4K
COST icon
68
Costco
COST
$422B
$25K ﹤0.01%
135
-93
-41% -$16.1K
DHR icon
69
Danaher
DHR
$137B
$24K ﹤0.01%
288
-174
-38% -$14.1K
ISRG icon
70
Intuitive Surgical
ISRG
$127B
$18K ﹤0.01%
144
-288
-67% -$36K
SBUX icon
71
Starbucks
SBUX
$120B
$16K ﹤0.01%
279
-295
-51% -$16.7K
MBLY
72
DELISTED
Mobileye N.V.
MBLY
$16K ﹤0.01%
255
MDT icon
73
Medtronic
MDT
$109B
$15K ﹤0.01%
182
-53
-23% -$4.25K
PEP icon
74
PepsiCo
PEP
$190B
$12K ﹤0.01%
103
XLNX
75
DELISTED
Xilinx Inc
XLNX
$12K ﹤0.01%
184
-175
-49% -$12.4K

Similar funds

Winslow Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Winslow Capital Management held 106 positions worth $18.2B, down 2.1% from $18.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Winslow Capital Management withdrew a net $1.52B in Q4 2017, closing 7 positions and reducing 55 holdings. Its most notable exit was JD.com, an estimated $193M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Winslow Capital Management opened a new position in Cognizant worth $218M.

  • Winslow Capital Management's largest Q4 2017 buy was Cognizant: 3,062,856 shares worth $218M.
  • Winslow Capital Management added most to Microsoft in Q4 2017, an estimated $159M increase.
  • Winslow Capital Management's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $376M.
  • Winslow Capital Management fully exited JD.com in Q4 2017, selling an estimated $193M.
  • Winslow Capital Management's ten largest holdings make up 35% of its $18.2B portfolio in Q4 2017.
  • Winslow Capital Management opened 10 new positions and closed 7 in Q4 2017.
  • Winslow Capital Management's portfolio value fell 2.1% quarter-over-quarter to $18.2B.

Based on Winslow Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.